C9orf72重复扩张诱导人类iPSC衍生的微细胞的新陈代谢功能障碍,并调节质神经交叉声
Marika Mearelli1,2, Insa Hirschberg1,2, Christin Weissleder3
1Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Glia
|September 1, 2025
概括
这种C9orf72突变会在肌缩侧面硬化症 (ALS) 中破坏细胞代谢. 微细胞显示高糖解活性和氧化应激,影响运动神经元的脆弱性.
科学领域:
- 神经科学
- 遗传学
- 细胞生物学
背景情况:
- C9orf72六核酸重复扩张是肌缩侧面硬化 (ALS) 和前性痴呆的主要遗传原因.
- 这种突变对细胞类型的特定代谢和免疫途径的影响尚不清楚.
研究的目的:
- 研究来自C9orf72患者的诱导多能干细胞 (iPSC) 衍生的神经元,星细胞和微质细胞的细胞类特异性代谢变化.
- 检查基底和炎症条件下的代谢变化及其对细胞间通信的影响.
主要方法:
- 使用来自C9orf72患者和同位素对照的iPSC衍生的运动神经元,星球细胞和微质细胞.
- 在基底和炎症条件下进行单细胞代谢分析.
- 开发了人类iPSC衍生的三种培养系统 (运动神经元,星球细胞,微质细胞) 来模拟细胞间效应.
主要成果:
- 与具有线粒体呼吸障碍的C9orf72运动神经元不同,C9orf72微细胞表现出高水平的糖解活性,氧化应激和代谢酶上调.
- 炎症刺激会加剧C9orf72微质中的代谢障碍.
- 在星球细胞中由微细胞驱动的代谢重编程有助于三种培养系统中的运动神经元脆弱性.
结论:
- 在ALS的发病过程中,微质在代谢失调和细胞间交叉声中发挥着中心作用.
- 针对免疫细胞中的代谢途径是ALS的潜在治疗策略.
相关概念视频
Pleiotropy
31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28


